Abstract
Background A quantitative estimate of pulmonary artery wedge pressures (PAWP) can be obtained using echocardiography, but including left atrial (LA) volume (ePAWP-LA) in the estimation may be misleading. We aimed to derive and validate a new estimate without LA volume information (ePAWP-NOLA) and compare its performance to the ASE/EACVI algorithms for diastolic dysfunction.
Methods ePAWP-NOLA was derived and validated in separate datasets of patients who had undergone right heart catheterization and echocardiography. Prognosis was assessed in the validation cohort and the National Echocardiography Database Australia (NEDA) using Cox regression adjusted for age, sex and left ventricular ejection fraction (LVEF).
Results In the derivation cohort (60±15 years, 40% males, 31% with LVEF<50%), ePAWP-NOLA was derived from mitral (E), and pulmonary vein systolic (S) and diastolic (D) Doppler velocities (n=134, mean difference±SD vs PAWP: 0.0±5.5 mmHg). In the validation cohort (n=116, 51±14 years, 69% males, 89% with LVEF<50%), PAWP agreed with both ePAWP-NOLA and ePAWP-LA (difference 1.3±6.1, 3.2±6.3 mmHg). PAWP>15 mmHg was accurately detected by both ePAWP-NOLA and ePAWP-LA (area under the curve (AUC): 0.84 [0.76–0.92], 0.80 [0.72–0.88]). AUC for the ASE/EACVI algorithm was lower ([0.69 [0.61–0.77]). ePAWP-NOLA and ePAWP-LA correlated with right ventricular afterload, associated with death or implantation of left ventricular assist device (hazard ratio: 1.09 [1.02–1.16], 1.07 [1.02–1.14]), and with cardiovascular death in NEDA (n=38,844, hazard ratio: 1.08 [1.07–1.09], 1.08 [1.07–1.09]).
Conclusions ePAWP-NOLA has diagnostic and prognostic performance comparable to ePAWP-LA, and improved diagnostic performance compared to the ASE/EACVI diastolic dysfunction algorithm.
Competing Interest Statement
TL: none; AM: none; GS: Consulting fees from NEDA; PL: None; DP: Consulting fees from NEDA; OBH: None; MU: none.
Funding Statement
This work has been funded in part by grants to TL from Region Kronoberg, Sweden, to MU from New South Wales Health, Heart Research Australia, and the University of Sydney, to PL from The Swedish Heart and Lung foundation (20160787, 20200160) and the Swedish Research Council (2019-01338).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
For the invasive cohorts, ethical approval was obtained from the Swedish Ethical Review Authority and informed consent was obtained from study participants. For the National Echocardiographic Database of Australia, ethical approval was obtained from the Royal Prince Alfred Human Research Ethics Committe, who waived informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The data underlying this article can be shared upon reasonable request to the corresponding author, except for the data obtained through the National Echocardiography Database of Australia.
Abbreviations
- E
- Mitral early peak wave velocity
- HF
- Heart failure
- LAVI
- Left atrial volume indexed to body surface area
- LAP
- Left atrial pressure
- LVEF
- Left ventricular ejection fraction
- LVFP
- Left ventricular filling pressures
- PAWP
- Pulmonary artery wedge pressure
- S
- Systolic pulmonary vein velocity
- D
- Diastolic pulmonary vein velocity
- RHC
- Right heart catheterization
